Evidence map›Paper›PMID 39123463›Full record

ArticleCancers2024

Insulin Resistance in Women Correlates with Chromatin Histone Lysine Acetylation, Inflammatory Signaling, and Accelerated Aging.

Christina M Vidal, Jackelyn A Alva-Ornelas, Nancy Zhuo Chen, Parijat Senapati, Jerneja Tomsic, Vanessa Myriam Robles, Cristal Resto, Nancy Sanchez, Angelica Sanchez, Terry Hyslop and 13 more

Abstract read
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Christina M VidalCity of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
Jackelyn A Alva-OrnelasCity of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
Nancy Zhuo ChenArthur Riggs Diabetes and Metabolism Research Institute, City of Hope Duarte, Duarte, CA 91010, USA.
Parijat SenapatiCity of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.ORCID 0000-0002-7324-1230
Jerneja TomsicCity of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.ORCID 0009-0007-0927-0428
Vanessa Myriam RoblesCity of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
Cristal RestoCity of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
Nancy SanchezCity of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
Angelica SanchezCity of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
Terry HyslopSidney Kimmel Cancer Center, Philadelphia, PA 19107, USA.
Nour EmwasCity of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.ORCID 0000-0002-0842-9640
Dana AljaberCity of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.ORCID 0000-0003-1733-7999
Nick BachelderArthur Riggs Diabetes and Metabolism Research Institute, City of Hope Duarte, Duarte, CA 91010, USA.
Ernest MartinezDepartment of Biochemistry, University of California at Riverside, Riverside, CA 92521, USA.ORCID 0000-0002-6326-4121
David AnnCity of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
Veronica JonesCity of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
Robert A WinnMassey Comprehensive Cancer Center, Virginia Commonwealth University, Richmond, VA 23298, USA.ORCID 0000-0001-5948-9291
Lucio MieleSchool of Medicine, Louisiana State University, New Orleans, LA 70112, USA.ORCID 0000-0002-5853-7287
Augusto C OchoaSchool of Medicine, Louisiana State University, New Orleans, LA 70112, USA.ORCID 0000-0001-6457-8029
Eric C DietzeCity of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
Rama NatarajanArthur Riggs Diabetes and Metabolism Research Institute, City of Hope Duarte, Duarte, CA 91010, USA.ORCID 0000-0003-4494-1788
Dustin SchonesArthur Riggs Diabetes and Metabolism Research Institute, City of Hope Duarte, Duarte, CA 91010, USA.
Victoria L SeewaldtCity of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.ORCID 0000-0002-7289-9268

Funding

Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI John Charles Williams · 1985 to 2026
$86.3M
Inflammatory Gene Transcription In Diabetic ConditionsR01DK065073 · NIDDK · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI NATARAJAN, RAMA · 2003 to 2021
$7.9M
Project 2U54CA285116 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI ERNEST MARTINEZ, Victoria L. Seewaldt · 2023 to 2026
$6.8M
Research EducationU54CA285114 · NCI · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI ERNEST MARTINEZ · 2023 to 2026
$6.2M
Diversity Supplement to Combined Breast MRI/Biomarker Strategies to Identify Aggressive BiologyU01CA189283 · NCI · DUKE UNIVERSITY · PI CLINTON, STEVEN K, MIRANDA-CARBONI, GUSTAVO ADOLFO · 2015 to 2020
$4.0M
Epigenetic damage in women living in LA food-desert zip codesR01CA220693 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI ANN, DAVID K., HYSLOP, TERRY · 2017 to 2021
$3.7M
Translational Research Center in Lung Cancer Disparities (TRACER)P20CA252717 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI HUGHES-HALBERT, CHANITA A., SEEWALDT, VICTORIA L. · 2021 to 2023
$3.2M
Cancer Metabolism Training ProgramT32CA221709 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI David K. Ann, Victoria L. Seewaldt · 2018 to 2026
$1.8M
2/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership (Pilot Project 2)P20CA242620 · NCI · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI MARTINEZ, ERNEST · 2019 to 2022
$1.2M
Project 2P20CA242619 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI SEEWALDT, VICTORIA L. · 2019 to 2022
$937k
NCI NIH HHS P20 CA242619NCI NIH HHS P20 CA242620NCI NIH HHS P20 CA252717NCI NIH HHS P30 CA033572NCI NIH HHS R01 CA220693NCI NIH HHS T32 CA221709NCI NIH HHS U01 CA189283NCI NIH HHS U54 CA285114NCI NIH HHS U54 CA285116NIDDK NIH HHS R01 DK065073NIH/NCI P20CA24619NIH/NCI P20CA252717NIH/NCI P30CA33572NIH/NCI R01CA220693NIH/NCI U01CA189283NIH/NCI U54CA285116
6 · The paper itself

Abstract

backgroundEpigenetic changes link medical, social, and environmental factors with cardiovascular and kidney disease and, more recently, with cancer. The mechanistic link between metabolic health and epigenetic changes is only starting to be investigated. In our in vitro and in vivo studies, we performed a broad analysis of the link between hyperinsulinemia and chromatin acetylation; our top "hit" was chromatin opening at H3K9ac.

methodsBuilding on our published preclinical studies, here, we performed a detailed analysis of the link between insulin resistance, chromatin acetylation, and inflammation using an initial test set of 28 women and validation sets of 245, 22, and 53 women.

resultsChIP-seq identified chromatin acetylation and opening at the genes coding for TNFα and IL6 in insulin-resistant women. Pathway analysis identified inflammatory response genes, NFκB/TNFα-signaling, reactome cytokine signaling, innate immunity, and senescence. Consistent with this finding, flow cytometry identified increased senescent circulating peripheral T-cells. DNA methylation analysis identified evidence of accelerated aging in insulin-resistant vs. metabolically healthy women.

conclusionsThis study shows that insulin-resistant women have increased chromatin acetylation/opening, inflammation, and, perhaps, accelerated aging. Given the role that inflammation plays in cancer initiation and progression, these studies provide a potential mechanistic link between insulin resistance and cancer.

Indexed as

chromatin acetylationepigeneticshistone H3K9acinsulin resistanceinterlukin-6 (IL6)SASPsenescencetissue inflammationTNF-alpha

Identifiers

PMID39123463
PMCPMC11311683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.